Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: Results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial

Andrea Ardizzoni, Marcello Tiseo, Luca Boni, Andrew D. Vincent, Rodolfo Passalacqua, Sebastiano Buti, Domenico Amoroso, Andrea Camerini, Roberto Labianca, Giovenzio Genestreti, Corrado Boni, Libero Ciuffreda, Francesco Di Costanzo, Filippo De Marinis, Lucio Crinò, Antonio Santo, Antonio Pazzola, Fausto Barbieri, Nicoletta Zilembo, Ida ColantonioCarmelo Tibaldi, Rodolfo Mattioli, Mara A. Cafferata, Roberta Camisa, Egbert F. Smit

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: Results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences